Connection
Cynthia Epperson to Biomarkers
This is a "connection" page, showing publications Cynthia Epperson has written about Biomarkers.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.049 |
|
|
|
-
Barone JC, Ho A, Osborne LM, Eisenlohr-Moul TA, Morrow AL, Payne JL, Epperson CN, Hantsoo L. Luteal phase sertraline treatment of premenstrual dysphoric disorder (PMDD): Effects on markers of hypothalamic pituitary adrenal (HPA) axis activation and inflammation. Psychoneuroendocrinology. 2024 Nov; 169:107145.
Score: 0.025
-
Jacobs PS, Jee J, Fang L, Devlin E, Iannelli C, Thakuri D, Loughead J, Epperson CN, Wilson N, Roalf D, Reddy R, Nanga RPR. Application of glutamate weighted CEST in brain imaging of nicotine dependent participants in vivo at 7T. PLoS One. 2024; 19(2):e0297310.
Score: 0.024